Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan-Erik Damber

Showing results (1-10 of 119) with videos related to

Pageof 12
Sort By:
Lakartidningen|October 16, 2003
[Mass screening for prostate cancer will have to wait. The scientific basis insufficient, more efficient markers necessary]Jan-Erik Damber
European Urology|November 8, 2015
Words of Wisdom. RE: Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant MelanomaJan-Erik Damber
Acta Oncologica (Stockholm, Sweden)|September 17, 2005
Endocrine therapy for prostate cancerJan-Erik Damber
Lancet (London, England)|May 20, 2008
Prostate cancerJan-Erik Damber, Gunnar Aus
Best Practice & Research. Clinical Endocrinology & Metabolism|March 15, 2011
Prostate diseases--role of sex steroids and their inhibitorsKarin Welén, Jan-Erik Damber
Reviews in Endocrine & Metabolic Disorders|June 24, 2022
Androgens, aging, and prostate healthKarin Welén, Jan-Erik Damber
Acta Oncologica (Stockholm, Sweden)|August 4, 2005
Thrombospondins, metallo proteases and thrombospondin receptors messenger RNA and protein expression in different tumour sublines of the Dunning prostate cancer modelChristina Vallbo, Jan-Erik Damber
Acta Oncologica (Stockholm, Sweden)|September 17, 2005
Surgical treatment of localized prostate cancerJan-Erik Damber, Ali Khatami
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|February 28, 2009
Increased p53 immunoreactivity in proliferative inflammatory atrophy of prostate is related to focal acute inflammationWanzhong Wang, Anders Bergh, Jan-Erik Damber
Acta Oncologica (Stockholm, Sweden)|August 4, 2005
Alteration of gonadotropin-releasing hormone receptor expression with the progression of prostate cancer in the Dunning rat adenocarcinoma sublinesAse Tieva, Anders Bergh, Jan-Erik Damber
Pageof 12

Showing results (1-10 of 119) with videos related to

Sort By:
Pageof 12
Lakartidningen|October 16, 2003
[Mass screening for prostate cancer will have to wait. The scientific basis insufficient, more efficient markers necessary]Jan-Erik Damber
European Urology|November 8, 2015
Words of Wisdom. RE: Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant MelanomaJan-Erik Damber
Acta Oncologica (Stockholm, Sweden)|September 17, 2005
Endocrine therapy for prostate cancerJan-Erik Damber
Lancet (London, England)|May 20, 2008
Prostate cancerJan-Erik Damber, Gunnar Aus
Best Practice & Research. Clinical Endocrinology & Metabolism|March 15, 2011
Prostate diseases--role of sex steroids and their inhibitorsKarin Welén, Jan-Erik Damber
Reviews in Endocrine & Metabolic Disorders|June 24, 2022
Androgens, aging, and prostate healthKarin Welén, Jan-Erik Damber
Acta Oncologica (Stockholm, Sweden)|August 4, 2005
Thrombospondins, metallo proteases and thrombospondin receptors messenger RNA and protein expression in different tumour sublines of the Dunning prostate cancer modelChristina Vallbo, Jan-Erik Damber
Acta Oncologica (Stockholm, Sweden)|September 17, 2005
Surgical treatment of localized prostate cancerJan-Erik Damber, Ali Khatami
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|February 28, 2009
Increased p53 immunoreactivity in proliferative inflammatory atrophy of prostate is related to focal acute inflammationWanzhong Wang, Anders Bergh, Jan-Erik Damber
Acta Oncologica (Stockholm, Sweden)|August 4, 2005
Alteration of gonadotropin-releasing hormone receptor expression with the progression of prostate cancer in the Dunning rat adenocarcinoma sublinesAse Tieva, Anders Bergh, Jan-Erik Damber
Pageof 12